Spyridopoulou, Katerina, Tiptiri-Kourpeti, Angeliki, Lampri, Evangeli, Fitsiou, Eleni, Vasileiadis, Stavros, Vamvakias, Manolis, Bardouki, Haido, Goussia, Anna, Malamou-Mitsi, Vasiliki, Panagiotidis, Mihalis, Galanis, Alex, Pappa, Aglaia and Chlichlia, Katerina (2017) Dietary mastic oil extracted from Pistacia lentiscus var. chia suppresses tumor growth in experimental colon cancer models. Scientific Reports, 7 (1). p. 3782. ISSN 2045-2322
|
Text (Article)
Scientific Reports (Published Manuscript).pdf - Published Version Available under License Creative Commons Attribution 4.0. Download (3MB) | Preview |
|
|
Text (Article)
Scientific Reports (Final Draft).pdf - Accepted Version Download (3MB) | Preview |
Abstract
Plant-derived bioactive compounds attract considerable interest as potential chemopreventive anticancer agents. We analyzed the volatile dietary phytochemicals (terpenes) present in mastic oil extracted from the resin of Pistacia lentiscus var. chia and comparatively investigated their effects on colon carcinoma proliferation, a) in vitro against colon cancer cell lines and b) in vivo on tumor growth in mice following oral administration. Mastic oil inhibited - more effectively than its major constituentsproliferation of colon cancer cells in vitro, attenuated migration and downregulated transcriptional expression of survivin (BIRC5a). When administered orally, mastic oil inhibited the growth of colon carcinoma tumors in mice. A reduced expression of Ki-67 and survivin in tumor tissues accompanied the observed effects. Notably, only mastic oil -which is comprised of 67.7% α-pinene and 18.8% myrceneinduced a statistically significant anti-tumor effect in mice but not α-pinene, myrcene or a combination thereof. Thus, mastic oil, as a combination of terpenes, exerts growth inhibitory effects against colon carcinoma, suggesting a nutraceutical potential in the fight against colon cancer. To our knowledge, this is the first report showing that orally administered mastic oil induces tumor-suppressing effects against experimental colon cancer.
Item Type: | Article |
---|---|
Subjects: | B200 Pharmacology, Toxicology and Pharmacy C900 Others in Biological Sciences |
Department: | Faculties > Health and Life Sciences > Applied Sciences |
Depositing User: | Ay Okpokam |
Date Deposited: | 20 Jun 2017 08:42 |
Last Modified: | 01 Aug 2021 03:48 |
URI: | http://nrl.northumbria.ac.uk/id/eprint/31160 |
Downloads
Downloads per month over past year